Sentences with phrase «president of oncology»

She is the current president of the Oncology Association of Naturopathic Physicians.

Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ to its Power 100 list.

We are equally pleased that Peter Cole, a highly accomplished clinician and researcher, will be leading our Pediatric Hematology / Oncology Program and helping to expand the depth and breadth of pediatric cancer treatment offerings across RWJBarnabas Health,» notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for RBHS.

Dr. Libutti, who is also senior vice president of oncology services at RWJBarnabas Health, joins other RWJBH and Rutgers colleagues on the list.

In this video, Steven Libutti, MD, Senior Vice President of Oncology Services, RWJBarnabas Health and Director, Rutgers Cancer Institute of New Jersey, explains why cancer care and cancer research are two sides of the same coin.

It is humbling that our peers recognize the passion and commitment of our team in carrying out this mission,» Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services for RWJBarnabas Health and vice chancellor for cancer programs at Rutgers Biomedical and Health Sciences, Rutgers University.

«There are many ways to access information about clinical trials,» offers Linda Krebs, past president of the Oncology Nursing Society.

Not exact matches

Also at GSK, she served as Vice President of Global Regulatory Affairs for Oncology, in addition to providing regulatory leadership on a number of innovation and operational excellence initiatives.

At US Oncology, Bruce served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board.

Dr. Amy P. Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health Dr. Kyu Rhee, Chief Health Officer and Vice President, IBM Dr. B. Vindell Washington, National Coordinator for Health Information Technology, U.S. Department of Health and Human Services Moderator: Michal Lev - Ram, Fortune

Participants included CEOs Jonathan Bush of Athenahealth, Ron Gutman of HealthTap, Dr. Clifford Hudis of the American Society of Clinical Oncology, Dr. Vivian Lee of University of Utah Health Care, VitalConnect CEO Nersi Nazari, James Park of Fitbit, and Andrew Witty of GSK, as well as President of Flex Health Solutions John Carlson, Multiple Myeloma Research Foundation Founder Kathy Giusti, Dr. Sanjay Gupta, Arianna Huffington, Andreessen Horowitz General Partner Vijay Pande, Parker Foundation President Sean Parker, Women's Alzheimer's Movement Founder Maria Shriver, and White House Cancer Moonshot Task Force Executive Director Greg Simon.

Monica Bertagnolli, chief of the Division of Surgical Oncology at Brigham and Women's Hospital and chair of the Alliance for Clinical Trials in Oncology, a nationwide effort to test new therapies, says she was thrilled that the president used the word «cure» in his speech at all.

«It has to be more of an individualized approach to the type of cancer and even the patient,» says the University of Nebraska, Omaha's Julie Vose, president of the American Society of Clinical Oncology (ASCO).

«While e-cigarettes may reduce smoking rates and attendant adverse health risks, we will not know for sure until these products are researched and regulated,» said Peter Paul Yu, president of the 35,000 - member American Society of Clinical Oncology, in a statement.

Maria Die Trill, president of the International Psycho - Oncology Society at the Hospital Gregorio Marañón in Madrid, wrote in a testimonial that she expected her PEN interview to help «spread the word» about the society.

«It's 11 questions, and it's not hard to do,» says Hurria, who just completed a two - year term as president of the International Society of Geriatric Oncology.

This was a «political decision inspired by a messianic surge of pseudoscience,» says Gustavo Fernandes, president of the Brazilian Society of Clinical Oncology in Brasília.

«NYGC is thrilled to have this work be our first published example of the explosive power of collaborations between deeply invested biologists like those in the Simon lab including Elana Simon, and thoughtful bioinformatics scientists like Nicolas Robine and NYGC team, who worked together so effectively with the tools of genomic sequencing and analysis to discover this new chimeric protein and cancer target,» says Robert Darnell, head of Rockefeller's Laboratory of Molecular Neuro - Oncology, HHMI investigator, and president and scientific director of NYGC.

Once tests and exams come back indicating cancer, says David S. Parda, MD, FACP, past president of the Pennsylvania Society of Oncology & Hematology, it's time for the patient and her physician - led health care team to come up with a plan to fight it.

«Mesothelioma remains a difficult disease to find better treatment options for, so we asked whether high - dose hemithoracic radiotherapy would decrease the rate or delay the time of local recurrence after chemotherapy and radical surgery,» says lead author Prof Rolf A. Stahel, from the Clinic and Policlinic for Oncology, at the University Hospital Zurich, Switzerland, and current President of the European Society for Medical Oncology.

«We are grateful to CRI and the hundreds of researchers who have contributed to this important resource,» said Justin Guinney, Ph.D., Vice President of Computational Oncology at Sage Bionetworks.

Most recently, Dr. Kanner served as Vice President of Discovery Biology at Arrowhead Pharmaceuticals, where he helped lead the discovery and development of novel RNAi - based therapeutics for oncology and genetic disease programs.

The announcement comes from Giuseppe Della Porta, IFOM President, Gabriele Galateri di Genola, IEO President, Piero Sierra, FIRC President, Pier Paolo Di Fiore, IFOM Scientific Director, Pier Giuseppe Pelicci, Chairman of the Experimental Oncology at IEO, and Umberto Veronesi, IEO Scientific Director.

He is a past president of the American Society of Pediatric Hematology / Oncology and is a member of the steering committee for Bone Tumors in the Children's Oncology Group.

Sharon O'Keefe, president of the University of Chicago Medical Center, led the ceremonial ribbon cutting, with Ravi Salgia, MD, director of the Chest Oncology and Thoracic Oncology Research Program, and his patient, Anthony Palumbo, holding the ends of the band.

Vice President Joe Biden's «Cancer Moonshot» initiative is an example of precision medicine in its goal of using big data and precision oncology techniques.

Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional sooncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional soOncology, the largest and one of the most influential oncology professional sooncology professional societies.

He also is Georgia Research Alliance Eminent Scholar and Chair in Cancer Research there, Lawrence W. Davis Professor and chairman of the Department of Radiation Oncology for the Emory University School of Medicine and associate vice president for cancer for Emory's Woodruff Health Sciences Center.

Theodore DeWeese, M.D., the Sidney Kimmel Professor and Director of Radiation Oncology and Molecular Radiation Sciences, was named vice president of interdisciplinary patient care for Johns Hopkins Medicine.

Currently, he is the Chief Scientific Officer of Oncology at Natera and the Founder and President of the Rare Genomics Institute.

Founder and President of the Rare Genomics Institute; Chief Scientific Officer, Oncology at Natera Inc..

Professor Michael Lee, Professor of Interventional Radiology at The Royal College of Surgeons in Ireland and Consultant Interventional Radiologist at Beaumont Hospital, Dublin was President of CIRSE between 2012 - 2013 CIRSE will be hosting The European Congress on Interventional Oncology in Dublin on the 17th - 20th of April 2016.

Dana - Farber Cancer Institute, Harvard Medical School, Boston MA, USA 1989 — 1991 Universitair Docent, Department of Clinical Immunology, University of Utrecht 1991 — 2002 Professor and Chairman, Dept. of Immunology, Faculty of Medicine, University of Utrecht 2002 — 2012 Director of the Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences 2002 — Professor in Molecular Genetics, University Medical Center Utrecht 2012 — 2015 President of the Royal Netherlands Academy of Sciences 2015 — Director Research of the Princess Máxima Center for pediatric oncology 2017 — Oncode Investigator

Sidney Kimmel Professor of Radiation Oncology and Molecular Radiation Sciences Vice President for Interdisciplinary Patient Care, Johns Hopkins Medicine

Panelists Margaret Offermann, MD, PhD (Bio) Vice President Elect for Science Policy Board of Directors at FASEB Treasurer and Member, Board of Directors at George Center for Oncology Research and Education

Frank Hsu joined Immune Design in October 2013 as Vice President, Head of Oncology.

ANN ARBOR, Mich. — Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Ooncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical OncologyOncology.

«Bristol - Myers Squibb is thrilled to be part of an innovative research model where each partner acts with urgency to advance potential new treatments for patients facing deadly cancers,» said Awny Farajallah, M.D., vice president, head of U.S. Medical Oncology at Bristol - Myers Squibb.

UC San Diego Moores Cancer Center Physician Appointed President of American College of Radiation Oncology

IASLC President and ELCC Steering Committee member, Giorgio Scagliotti, said: «Fabrice Barlesi is among the European leaders in the field of translational research in thoracic oncology and he is also an outstanding physician.

He served as president to the Colorado Association of Naturopathic Physicians and is on the board of directors of the Oncology Association of Naturopathic Physicians.

She is Past President of both AIMVT (Academy of Internal Medicine for Veterinary Technicians) and the VTCS (Veterinary Technician Cancer Society) and now mentors applicants seeking their specialty credentialing in oncology.

She has served on the American College of Veterinary Internal Medicine (ACVIM) Board of Regents and is past president of both the Veterinary Cancer Society and the ACVIM Specialty of Oncology.

Dr. Frank J DeFeis, Central Veterinary Associates» Senior Vice President and Director of Oncology, Acupuncture and Homeopathic Medicine, has achieved...

Dr. Post is a board - certified specialist in veterinary oncology and the Founder and President of the Animal Cancer Foundation.

He has served as president and chairman of the Board of Regents for the American College of Veterinary Internal Medicine and is a founding Diplomate of the ACVIM Specialty of Oncology.

Past professional roles include President of the Veterinary Cooperative Oncology Group, member - at - large for the Veterinary Cancer Society, and Chair of the Oncology Certifying Examination Committee.

Appointed by the Region Director President's Council cross-functional advisory to the President of Pfizer Oncology to oversee national sales training to align with corporate goals.

Career Highlights * Launched blockbuster Oncology product Opdivo, promoting 8 indications across 6 tumor types within 2 years on market (Nov 2015 - current) * Winner of National Lead 2gether 2 Win Sales Contest 2017, Opdivo National Launch Sales Contest 2015, Region Two Ways to Win Sales Contest 2015, Innovation Award 2016 * Appointed to Vice President's Advisory Board three years in a row -2014-2017 * Developed and Drove R...